NFKB1 and pulmonary arterial hypertension: As NF-κB dyshomeostasis might be predictive of PPH, it would be beneficial to identify safe agents to efficiently modulate the NF-κB signaling pathway for prevention or treatment of EH starting at the neonatal stage.